Radiation Therapy for Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma
- 1 January 2024
- book chapter
- Published by Springer Nature
- p. 265-284
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Radiotherapy as a bridging strategy for patients with relapsed or refractory large B‐cell lymphoma undergoing CAR T‐cell therapyAmerican Journal of Hematology, 2024
- Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyTransplantation and Cellular Therapy, 2022
- Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphomaCochrane Database of Systematic Reviews, 2013
- Long-term follow-up of salvage radiotherapy in Hodgkin’s lymphoma after chemotherapy failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993